Chilton Investment Company’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-7,702
Closed -$387K 148
2018
Q1
$387K Sell
7,702
-1,926
-20% -$113K 0.01% 119
2017
Q4
$634K Sell
9,628
-748,634
-99% -$47.6M 0.02% 97
2017
Q3
$45.4M Sell
758,262
-211,843
-22% -$12.6M 1.75% 21
2017
Q2
$62.9M Sell
970,105
-114,460
-11% -$7.23M 2.42% 13
2017
Q1
$67.7M Buy
1,084,565
+361,278
+50% +$21.7M 2.64% 16
2016
Q4
$41.8M Buy
723,287
+660,725
+1,056% +$39M 1.69% 23
2016
Q3
$3.72M Buy
62,562
+53,656
+602% +$3.3M 0.15% 52
2016
Q2
$553K Hold
8,906
0.02% 103
2016
Q1
$549K Buy
+8,906
New +$525K 0.02% 97
2014
Q4
Sell
-19,740
Closed -$900K 190
2014
Q3
$900K Buy
+19,740
New +$929K 0.03% 128

Other funds holding XRAY

Chilton Investment Company's XRAY Position: Q2 2018 in Review

Chilton Investment Company sold out of Dentsply Sirona (XRAY) in Q2 2018, closing a stake of 7,702 shares — an estimated $387K sold.

Chilton Investment Company first reported a position in XRAY in Q3 2014 and held it in 10 quarters. The position peaked at $67.7M in Q1 2017. 540 funds tracked by Wall St. Rank hold XRAY as of Q2 2018.

  • Chilton Investment Company reported no remaining Dentsply Sirona position as of Q2 2018 after selling out during the quarter.
  • Chilton Investment Company sold 7,702 Dentsply Sirona shares in Q2 2018, an estimated $387K.
  • Chilton Investment Company first reported a position in Dentsply Sirona in Q3 2014 and held it in 10 quarters.
  • Chilton Investment Company's Dentsply Sirona position peaked at $67.7M in Q1 2017.
  • 540 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2018.

Based on Chilton Investment Company's 13F filing for Q2 2018, filed 10 Aug 2018.